{"title":"治疗复发或难治套细胞淋巴瘤的 Pirtobrutinib:使用概况","authors":"Young-A Heo","doi":"10.1007/s40267-023-01041-w","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505222,"journal":{"name":"Drugs & Therapy Perspectives","volume":"2 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pirtobrutinib in relapsed or refractory mantle cell lymphoma: a profile of its use\",\"authors\":\"Young-A Heo\",\"doi\":\"10.1007/s40267-023-01041-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505222,\"journal\":{\"name\":\"Drugs & Therapy Perspectives\",\"volume\":\"2 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs & Therapy Perspectives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40267-023-01041-w\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Therapy Perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40267-023-01041-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}